Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 6, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Francois Brisebois Maintained (BNGO) at Buy with Decreased Target to $90 on, Feb 6th, 2023
Francois Brisebois of Oppenheimer, Maintained "Bionano Genomics, Inc." (BNGO) at Buy with Decreased Target from $120 to $90 on, Feb 6th, 2023.
Francois has made no other calls on BNGO in the last 4 months.
There are 2 other peers that have a rating on BNGO. Out of the 2 peers that are also analyzing BNGO, 0 agree with Francois's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Francois
- Mark Massaro of "BTIG" Maintained at Strong Buy and Held Target at $35 on, Sunday, February 5th, 2023
- Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $40 on, Thursday, January 5th, 2023
